Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Pharmaceuticals ETF (XPH)

Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that- before fees and expenses- correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index")- the fund employs a sampling strategy. It generally invests substantially all- but at least 80%- of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Pharma ETFs Down Post Q3 Earnings
Nov 09 / Zacks.com - Paid Partner Content
What Lies in Store for Pharma ETFs?
Nov 07 / Zacks.com - Paid Partner Content


1 month-2.31% 3 years-4.46%
3 months+3.45% 5 years+12.79%
1 year+2.00% Since inception+11.31%
Data through 11/18/2017

Quote Details

Previous close$41.90
Open day’s range41.63 – 42.00
Net asset value (NAV)41.89 (11/17/2017)
Daily volume127,373
Average volume (3 months)98,943
Data as of 3:59pm ET, 11/17/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+12.79%+16.79%
Expense Gross exp ratio0.35%1.33%
Risk 5 year sharpe ratio0.601.11
Net assets$399.9M$3.1B
Average market cap$9.4B$27.3B
Average P/E27.222.4
Dividend / Share--0.28%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
MYL Mylan NV5.35%
JNJ Johnson & Johnson5.12%
PFE Pfizer4.95%
LLY Eli Lilly and Co4.75%
ZTS Zoetis Inc4.74%
BMY Bristol-Myers Squibb4.74%
AKRX Akorn Inc4.73%
PRGO Perrigo Company PLC4.71%
HZNP Horizon Pharma PLC4.66%
JAZZ Jazz Pharmaceuticals PLC4.47%